Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets

Authors:

Abstract
Extract Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease thought to result from an aberrant response to lung injury, culminating in an exaggerated healing response with excessive deposition of extracellular matrix in the interstitium [1].
Funding Information
  • Instituto Tecnológico y de Energías Renovables (OA23/043)
  • Medical Research Council (MR/V00235X/1)
  • GlaxoSmithKline / Asthma + Lung UK Chair in Respiratory Research (C17-1)
  • Wellcome Trust (201291/Z/16/Z)
  • Wellcome Trust (218505/Z/19/Z)
  • Wellcome Trust (221680/Z/20/Z)
  • Instituto de Salud Carlos III (PI20/00876, PI23/00980, CB06/06/1088,)
  • Instituto de Salud Carlos III (PMP22/00083)
  • National Heart, Lung, and Blood Institute (R56HL158935 and K23HL138190)